"Therapy-related myeloid leukaemias, also referred to as therapy-related myeloid neoplasms, occur as a late complication after cytotoxic therapies (e.g. chemotherapy, immunosuppressive therapy, and radiation therapy) performed to treat other conditions. They represent haematological malignancies in which a causal relationship has been implied and have been recognised as distinct entities by the WHO classification of tumours of haematopoietic and lymphoid tissues."
"therapy-related acute myeloid leukaemia (t-AML)"